The Rakai Health Sciences Program (RHSP) has been at the forefront of HIV research, prevention, and healthcare innovation for over three decades. The Strategic Plan 2024-2028 serves as a blueprint for RHSP’s continued commitment to high-impact research, evidence-based healthcare services, and sustainable partnerships. The plan aligns with global health priorities, including UNAIDS 95-95-95 targets and Sustainable Development Goals (SDGs), ensuring RHSP’s relevance in an evolving healthcare landscape.
Key Focus Areas
1. Expanding Research & Innovation
RHSP aims to diversify its research to address emerging and re-emerging health threats, including climate change, pandemics, and non-communicable diseases (NCDs). The organization will continue its HIV surveillance and prevention research, leveraging its long-standing Rakai Community Cohort Study (RCCS) to inform national and global policies.
2. Strengthening Disease Prevention & Care
The plan emphasizes enhanced healthcare service models, improving access to HIV care, prevention, and treatment. RHSP will optimize data-driven healthcare interventions, integrate NCD management with HIV care, and expand community-centered services to eliminate disparities.
3. Building Strategic Partnerships & Infrastructure
RHSP will strengthen local and international partnerships to expand its impact. The organization will invest in state-of-the-art research and healthcare infrastructure, including laboratory advancements, digital health solutions, and sustainable funding mechanisms.
4. Advancing Training & Mentorship
A key pillar of the strategy is capacity building. RHSP will transform its training programs into a center of excellence, equipping healthcare professionals and researchers with cutting-edge skills to address public health challenges.
The Path Forward
With a people-centered, research-driven, and innovation-focused approach, RHSP is set to reshape public health outcomes in Uganda and beyond. By leveraging global partnerships and data-driven strategies, the organization aims to sustain progress in HIV control, healthcare delivery, and medical research over the next five years.